Alzheimer?s Disease-Related Administrative Supplement to DP1 DA041722 under NOT-AG-18-039 PROJECT SUMMARY Alzheimer?s disease (AD) prevalence is increasing and already affects over 5% of those over age 65. While AD manifests amyloid plaques and tau tangles, loss of synapses and neurons more closely correlates with cognitive decline. Damage to neurons occurs at least partially through generation of oxidative and nitrosative stress, due to excessive generation of reactive oxygen/nitrogen species (ROS/RNS) triggered in part by oligomeric amyloid-? (A?) peptide. Our group has shown that a predominant reaction in this regard is aberrant S-nitrosylation of critical cysteine residues that affect protein function/activity. In a prior year?s supplement, we used our innovative Mass Spectrometry (MS) platform to elucidate the S-nitrosoproteome in postmortem human AD brain similar to the parent grant looking at HIV-associated neurocognitive disorder (HAND) and HAND/methamphetamine exposed human brains. In Preliminary Studies, we have shown that S-nitrosylation of a network of proteins in AD and HAND/meth may contribute to synaptic damage and loss. Strikingly, we found, among other pathways, that the TCA cycle displays multiple aberrant S- ntrosylated enzymes, disrupting its function. We now propose in this supplement to model these findings in AD hiPSC-patient derived neuronal cultures and cerebral organoids in order to test small molecules that might be able to treat the resulting loss of ATP/bioenergetic supply and resulting neuronal and synaptic injury. This model system would be performed in parallel to work being performed in the parent grant on HIV/meth exposed hiPSC-derived neurons. Hence, the new proposed studies on hiPSC-derived neurons and cerebral organoids are within the scope of the parent project. Accordingly, we propose the following Specific Aims:
Aim 1 : To determine the S-nitrosoproteome, specifically with regard to its aberrant inhibition of TCA cycle enzymes, in human AD hiPSC neuronal cultures and cerebral organoids, and compare/contrast the pathways involved to those encountered in HIV-associated neurocognitive disorder (HAND) and HAND with methamphetamine abuse in both human brain cortex and hiPSC-derived neurons.
Aim 2 : To test small molecules related to succinate for their ability to bypass steps in the TCA cycle inhibited by aberrant S-nitrosylation in order to rescue energy compromised and consequent neuronal damage in AD hiPSC neuronal cultures and cerebral organoids.

Public Health Relevance

AD-Related Administrative Supplement to DP1 DA041722 under NOT-AG-18-039 NARRATIVE Alzheimer?s disease (AD) is the major cause of dementia in people over age 65, while HIV-associated neurocognitive disorder (HAND) occurs in the majority of people with AIDS and also appears with increasing age. In this ADMINISTRATIVE SUPPLEMENT under NOT-AG-18-039, we will determine if an aberrant chemical reaction, called protein S-nitrosylation, which we have found contributes to damage in individuals with HAND, especially in the face of drug abuse, also contributes to AD pathology by studying human AD hiPSC neurons and cerebral organoids ? this hiPSC preparation will allow us to determine mechanism of pathological action. The proposed study will allow us to test specific agents that can ameliorate the neuronal damage observed in AD and related pathologies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
3DP1DA041722-05S1
Application #
9879971
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Satterlee, John S
Project Start
2016-04-01
Project End
2021-02-28
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Connolly, Niamh M C; Theurey, Pierre; Adam-Vizi, Vera et al. (2018) Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ 25:542-572
Mann, Aman P; Scodeller, Pablo; Hussain, Sazid et al. (2018) Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease. Nat Commun 9:1070
Moore, David J; Fazeli, Pariya L; Moore, Raeanne C et al. (2018) Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS. AIDS Behav 22:1551-1561
Nagar, Saumya; Noveral, Sarah M; Trudler, Dorit et al. (2017) MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress. Proc Natl Acad Sci U S A 114:E4048-E4056
Mann, Aman P; Scodeller, Pablo; Hussain, Sazid et al. (2017) Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease. Nat Commun 8:1403
Tu, Shichun; Akhtar, Mohd Waseem; Escorihuela, Rosa Maria et al. (2017) NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nat Commun 8:1488
Oh, Chang-Ki; Sultan, Abdullah; Platzer, Joseph et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Rep 21:2171-2182
Satoh, Takumi; Lipton, Stuart (2017) Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate. F1000Res 6:2138
Nakamura, Tomohiro; Lipton, Stuart A (2017) 'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders. Trends Endocrinol Metab 28:879-892
Nagar, Saumya; Trudler, Dorit; McKercher, Scott R et al. (2017) Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. Invest Ophthalmol Vis Sci 58:3741-3749

Showing the most recent 10 out of 17 publications